.svg){kind=small}
Aug-2026
Sales
Trend
6-Month
Product Count
SKUs
Avg Price
YoY Sales Change
YoY Price Change
Market Insights Snapshot
In August 2026, Tinctible is entirely concentrated in Tincture & Sublingual, with category share at 100.0% and a year-over-year sales change of -87.54% paired with a month-over-month decline of -18.72%. The average price fell -18.61% year over year to $16.45, while sales contraction outpaced pricing decline, indicating volume loss beyond price-driven effects. With the brand’s top state listed as Ohio and no rank reported in the Tincture & Sublingual context, the absence of diversification combined with double-digit monthly contraction suggests a narrowing route-to-market where price cuts did not stabilize demand.
The single-category exposure, alongside a -87.54% annual drop and -18.72% monthly slide in August 2026, implies that Tinctible’s positioning is tethered to a shrinking niche where price decreases of -18.61% did not translate to share defense. With 100.0% of sales in Tincture & Sublingual and no current rank in Ohio, the mix signals a need to recalibrate assortment and channel focus, because the current configuration concentrates risk and weakens visibility in rank-based discovery.
Competitive Landscape
Tinctible ranks #9 in Ohio Tincture & Sublingual in August 2026, down 2 positions year over year from #7 and 3 positions from May 2026’s #6, while still trailing its peak of #4 reached in February 2025. Competitively, UB GOOD holds #1 with a 6.9% year-over-year sales lift as Doctor Solomon's advanced from #5 to #3, contrasting with Avexia sliding from #3 to #5 alongside an 81.1% sales decline. Against this backdrop, Standard Farms remains at #4 with a 61.0% sales contraction, while Butterfly Effect - Grow Ohio stays at #2 despite an 8.6% drop, indicating that Tinctible’s shift from #6 in May 2026 to #9 in August 2026 amid mixed competitor momentum implies a slide from the leading pack and a need to counter gains by advancing brands.
Notable Products
Squeeze In- CBD/THC 1:1 Spark Watermelon Gel 11-Pack (110mg CBD, 110mg THC) posted a -24.6% month-over-month decline and slid to rank 2, while Squeeze In- THC/CBG/CBD 2:1:1 Relief Blue Raspberry Gel 11-Pack (110mg THC, 55mg CBG, 55mg CBD) rose +19.4% and held rank 1. Two of the top two SKUs are Tincture & Sublingual, concentrating the lineup in a single format even as the third listed SKU carried no rank and no sales in August 2026, implying stalled breadth alongside depth at the top. The rank stability at 1 combined with a rank 2 drop and a single-month sales total of $1,480 for the leader points to a portfolio leaning on one flagship while a formerly balanced 1:1 product retrenches, suggesting Tinctible is tilting toward relief-led blends over broad-spectrum parity products.
Top Selling Cannabis Brands
Data for this report comes from real-time sales reporting by participating cannabis retailers via their point-of-sale systems, which are linked up with Headset’s business intelligence software. Headset’s data is very reliable, as it comes digitally direct from our partner retailers. However, the potential does exist for misreporting in the instance of duplicates, incorrectly classified products, inaccurate entry of products into point-of-sale systems, or even simple human error at the point of purchase. Thus, there is a slight margin of error to consider. Brands listed on this page are ranked in the top twenty within the market and product category by total retail sales volume.
